1/11/2023 Association of race and ethnicity with obstructive coronary artery disease Rooprai J, Qiu F, PorterJ, Abdel-Qadir H, Godoy LC, Jackevicius CA, Lee DS, Madan M, Shah BR, Sud M, Wijeysundera HC, Ko DT. JACC Adv. 2023; Jan 11 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.jacadv.2022.100161
12/23/2022 Primary care clinical volumes, cholesterol testing, and cardiovascular outcomes Udell JA, Brickman AR, Chu A, Ferreira-Legere LE, Sheth MS, Ko DT, Austin PC, Abdel-Qadir H, Ivers NM, Bhatia RS, Farkouh ME, Stukel TA, Tu JV. Can J Cardiol. 2022; Dec 23 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.cjca.2022.12.016
12/14/2022 Eligibility and implementation of rivaroxaban for secondary prevention of atherothrombosis in clinical practice-insights from the CANHEART study Sheth MS, Yu B, Chu A, Porter J, Tam DY, Ferreira-Legere LE, Goodman SG, Farkouh ME, Ko DT, Abdel-Qadir H, Udell JA. J Am Heart Assoc. 2022; 11(24):e026553. Epub 2022 Dec 14. DOI: https://doi.org/10.1161/JAHA.122.026553
The Star4/4/2021Article Dr. Homer Tien, president of Ornge, to lead Ontario’s COVID-19 vaccine task force